Category: ADC Technology

NewsWatch is a television program which is broadcast weekly on the AMC and ION networks. Over 1,200 episodes have aired since 1989. The main topics discussed on the show are an eclectic montage of health-related issues, fashion, tourism, business, sponsored consumer electronic reviews, new product releases, celebrity interviews, and public awareness announcements.

NewsWatch has shown to be a potent tool for marketers. The program grants NewsWatch’s partners access to all the top media markets in the US. Furthermore, through NewsWatch’s online TV station, marketers can target their audience thanks to the power of social media. Social media makes NewsWatch’s high-quality video content available to relevant audiences at all times of the day.

Examples of the results achievable for companies partnering with NewsWatch:

Avanca, the electronics company which wanted to use crowdfunding to finance a new pocket PC product. NewsWatch produced a one minute video for the company. The result was a campaign which raised $456,000 vs. their target of $10,000. The video had 1 million impressions on social media.

Then there is the case of Contour, the manufacturer of ergonomic workstations. NewsWatch produced a video for them, and their “Ultimate Work Station” saw an immediate spike in sales. Their video had more than half a million impressions.

Saygus, a US-based smartphone maker desired to conduct a crowdfunding campaign. They had NewsWatch produce a video for them, and the result was a success. Saygus hoped to raise $1 million. Instead, They managed to take in $1.3 million.

Steelseries, makers of headphones and electronics, needed a marketing video. NewsWatch produced review videos for two separate projects, which helped them reach 95 million households in the US. The company’s marketing director attributed their increased distribution to their new means to target potential customers.

To get straight to the point, Clay Siegall is the heart and the soul of cancer research. He has always had a passion for medicine and for technology as the two seem to go hand-to-hand to some degree. Clay Siegall, M.D., Ph.D., has a burning passion to eradicate this illness from the face of the earth, but it’s easier said than done. The amount of time that goes into producing these advanced drugs is rather large. After the production of the drugs, they’ll need to get approved by the FDA and the amount of time is furthermore extended. In all honesty, if you work in this field, you’ll certainly need perseverance.

Dr. Siegall has an extended educational-base. He has earned a Ph.D in Genetics from the affluent George Washington University, and he has earned a B.S. in Zoology from the prominent University of Maryland. His educational foundation is rock-solid at this point in time, but he is always thirsting for more. His exquisite thirst for knowledge has paid-off in huge returns. The returns just so happens to be people’s lives and you can’t put a price tag on that. “I would be lying if I said that money wasn’t motivating me,” said Dr. Siegall. In all honesty, it takes money to make money. The worlds economy was built-off buying and selling. There is no one that can say that this man is only doing this for monetary gain because all you’ll need to do is to look at his impressive resume of saving lives.

International marking is the next step for Dr. Siegall and Seattle Genetics. Once he gets this progressive system up-and-running, the sky is the limit. There won’t be any other organization or any other entity that will be able to pull Seattle Genetics’ strings.